Long-term survival in renal transplant patients: experience in social security
DOI:
https://doi.org/10.70108/nefrologiapy.2023.1.1.3Keywords:
graft survival, renal transplantation, social securityAbstract
Introduction: The best therapeutic alternative for patients affected by end-stage chronic kidney disease is kidney transplantation.
General objective: To characterize the long-term survival of patients with kidney transplants belonging to the Central Hospital of the Social Welfare Institute.
Specific objectives: Describe the factors associated with kidney graft failure. Evaluate the causes of kidney graft failure. List the complications related to the transplant
Patients and methods: Retrospective, descriptive, cross-sectional study, 173 medical records of people over 18 years of age under regular follow-up by the Transplant Service of the Central Hospital “Dr. Emilio Cubas” from the Social Welfare Institute.
Conclusion: The long-term survival of renal transplantation represents 99% at one year, 91% at three years, and 81% at five years.
Downloads
Metrics
References
(1) Kakitapalli Y, Ampolu J, Madasu SD, Sai Kumar MLS. Detailed Review of Chronic Kidney Disease. Kidney Dis. 2020;6(2):85-91.
(2) Auglienė R, Dalinkevičienč E, Kuzminskis V, Jievaltas M, Peleckaitė L, Gryguc A, et al. Factors influencing renal graft survival: 7-Year experience of a single center. Medicina (Mex). 2017;53(4):224-32.
(3) Zhang JY, Zhang HC, Suo CJ, Gu M. Graft survival of en bloc versus single kidney transplantation from small pediatric donors: a meta-analysis with trial sequential analysis. AME Med J [Internet]. 25 de agosto de 2017 [citado 10 de abril de 2021];2(8). Disponible en: https://amj.amegroups.com/article/view/4007
(4) Carney EF. The impact of chronic kidney disease onglobal health. Nat Rev Nephrol. mayo de 2020;16(5):251-251.
(5) Fu R, Sekercioglu N, Berta W, Coyte PC. Cost-effective- ness of Deceased-donor Renal Transplant Versus Dialysis to Treat End-stage Renal Disease: A Systematic Review. Transplant Direct. febrero de 2020;6(2):e522.
(6) Ayala-Servín N. Donación de órganos en Paraguay: una ley para combatir los últimos lugares de américa latina. Rev Cient Cienc Medica. 31 de julio de 2020;23(1):104-104.
(7) Arellano N. Donation and transplant of organs in Paraguay. An Fac Cienc Médicas Asunción. 30 de diciembre de 2018;51(3):13-6.
(8) Lee CY, Yang CY, Lin WC, Chen CC, Tsai MK. Prognostic factors for renal transplant graft survival in a retros- pective cohort of 1000 cases: The role of desensitization therapy. J Formos Med Assoc. 1 de abril de 2020; 119(4):829-37.
(9) Helfer MS, Pompeo J de C, Costa ORS, Vicari AR, Ribeiro AR, Manfro RC. Long-term effects of delayed graft function duration on function and survival of deceased donor kidney transplants. Braz J Nephrol. junio de 2019;41(2):231-41.
(10) Langewisch E, Mannon RB. Chronic Allograft Injury. Clin J Am Soc Nephrol [Internet]. 5 de abril de 2021 [citado 12 de abril de 2021]; Disponible en: https://cjasn.asnjournals.org/content/early/2021/02/17/CJN.15590920
(11) Law JP, Borrows R, McNulty D, Sharif A, Ferro CJ. Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients. BMC Nephrol. diciembre de 2021;22(1):102.
(12) Kamar N, Lepage B, Couzi L, Albano L, Durrbach A, Pernin V, et al. A Randomized Prospective Study Comparing Anti–T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients. Kidney Int Rep. 1 de agosto de 2020;5(8):1207-17.
(13) Krisl A, Stampf S, Hauri D, Binet I, Mueller T, Sidler D, et al. Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study. Swiss Med Wkly [Internet]. 5 de diciembre de 2020 [citado 11 de abril de 2021]; Disponible en: https://doi.emh.ch/smw.2020.20354
(14) Devine PA, Courtney AE, Maxwell AP. Cardiovascular risk in renal transplant recipients. J Nephrol. junio de 2019;32(3):389-99.
(15) Pagonas N, Bauer F, Seibert FS, Seidel M, Schenker P, Kykalos S, et al. Intensive blood pressure control is associated with improved patient and graft survival after renal transplantation. Sci Rep. diciembre de 2019; 9(1):10507.
(16) Wu DA, Robb ML, Forsythe JLR, Bradley C, Cairns J, Draper H, et al. Recipient Comorbidity and Survival Outcomes After Kidney Transplantation: A UK-wide Prospective Cohort Study. Transplantation. junio de 2020;104(6):1246-55.
(17) Hernández Sampieri R, Fernández Collado C, Baptista Lucio M del P. Metodología de la Investigación [Internet]. sexta. México: McGRAW-HILL / INTERAMERICANA EDITORES, S.A. DE C.V; 2014. 634 p. Disponible en: https://www.uca.ac.cr/wp-content/uploads/2017/10Investigacion.pdf
(18) Marconi B, Campanati A, Giannoni M, Ricotti F, Bianchelli T, Offidani A. Analysis of neoplastic skin complica- tions in transplant patients: experience of an Italian multidisciplinary transplant unit. G Ital Dermatol Venereol [Internet]. julio de 2020 [citado 10 de mayo de 2021];155(3). Disponible en: https://www.minervamedica. it/index2.php?show=R23Y2020N03A0325
(19) Campistol JM. Neoplasias en el Trasplante Renal | Nefrología al día [Internet]. 2019 [citado 10 de mayo de 2021]. Disponible en: http://www.nefrologiaaldia.org/es-articulo-neoplasias-el-trasplante-renal-211
(20) Branchereau J, Karam G, Prudhomme T. Complicaciones urinarias del trasplante renal. EMC - Urol. mayo de 2020;52(2):1-9.
(21) Thongprayoon C, Hansrivijit P, Leeaphorn N, Acharya P, Torres-Ortiz A, Kaewput W, et al. Recent Advances and Clinical Outcomes of Kidney Transplantation. J Clin Med. 22 de abril de 2020;9(4).
(22) Guzmán GE, Victoria AM, Ramos I, Maldonado A, Manzi E, Contreras-Valero JF, et al. Risk Factors Related to New-Onset Diabetes after Renal Transplantation in Patients of a High Complexity University Hospital in Colombia, 20 Years of Experience. Int J Endocrinol. 30 de agosto de 2020;2020:e8297192.
(23) Bicalho PR, Requião-Moura LR, Arruda ÉF, Chinen R, Mello L, Bertocchi APF, et al. Long-Term Outcomes among Kidney Transplant Recipients and after Graft Failure: A Single-Center Cohort Study in Brazil. BioMed Res Int. 2 de abril de 2019;2019:1-10.
(24) Kawano PR, Yamamoto HA, Gerra R, Garcia PD, Contti MM, Nga HS, et al. A case report of venous thrombosis after kidney transplantation – We can save the graft? Time is the success factor. Int J Surg Case Rep. 19 de mayo de 2017;36:82-5.
(25) de Teresa Alguacil FJ, de Gracia Guindo C, Fuentes CR, Carrasco RC, Marfil AP, Sacristán PG, et al. Patient’s Death with a Functioning Graft is still the Most Common Cause of Kidney Transplant Loss. Transplantation. julio de 2018;102:S555.
(26) So S, Au EHK, Lim WH, Lee VWS, Wong G. Factors Influencing Long-Term Patient and Allograft Outcomes in Elderly Kidney Transplant Recipients. Kidney Int Rep. marzo de 2021;6(3):727-36.
(27) Mottola C, Girerd N, Duarte K, Aarnink A, Giral M, Dantal J, et al. Prognostic value for long-term graft survival of estimated glomerular filtration rate and proteinuria quantified at 3 months after kidney transplantation. Clin Kidney J. 1 de octubre de 2020;13(5):791-802.
(28) Parajuli S, Mandelbrot DA, Aziz F, Garg N, Muth B, Mohamed M, et al. Characteristics and Outcomes of Kidney Transplant Recipients with a Functioning Graft for More than 25 Years. Kidney Dis Basel Switz. noviembre de 2018;4(4):255-61.
(29) Guerrero-Ramos F, Cavero-Escribano T, Rodriguez- Antolin A, de la Rosa-Kehrmann F, Pamplona-Casamayor M, Duarte-Ojeda JM, et al. Survival Analysis of Kidney Transplants with Grafts from Uncontrolled DCD Donors under Normothermic Preservation Prior to Organ Retrieval Related to DBD: Data from our 300 Transplants Series. Transplantation. julio de 2018;102:S408.
(30) García-Padilla PK, Vargas-Brochero MJ, Hurtado-Uriarte M, González-González CA, Rodríguez-Sánchez MP, Patiño JA, et al. Caracterización de trasplantados renales con donantes de criterios expandidos. Acta Médica Colomb [Internet]. 26 de junio de 2019 [citado 9 de mayo de 2021];44(3). Disponible en: http://actamedicacolombiana.com/ojs/index.php/actamed/article/view/1185
(31) Radilla-Ramos D, Rojas-Hernández G, Barajas-González S, Espinosa-Mercado L, Sandoval-Quintana JS. Protocolo ajustado a segundo nivel de atención para trasplante renal de donante vivo, experiencia en supervivencia en un centro del Instituto Mexicano del Seguro Social. Rev Mex Traspl. 2020;9(2):56-63.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Juan Acosta, Pablo Jara, Adriana Martínez, María Gloria Orue, María Magdalena Mayor, María del Carmen Romero, Roger Ayala
This work is licensed under a Creative Commons Attribution 4.0 International License.
